LONDON, Jan. 31, 2018 /PRNewswire/ — The vascular grafts market is expected to reach USD 3.80 billion by 2022 from USD 2.67 billion in 2017, at a CAGR of 7.3%. The major factors driving the growth of this market are the high burden of abdominal aneurysms, increasing geriatric population, and increasing prevalence of smoking & other […]
Financial
Varian to Discuss Agreement to Acquire Sirtex
PALO ALTO, Calif., Jan. 30, 2018 /PRNewswire/ — Varian (NYSE: VAR) today announced that it will webcast a conference call to discuss the details of the agreement, also announced today, to acquire all the outstanding shares of Sirtex Medical. Sirtex is an Australia-based global life sciences company focused on interventional oncology therapies, that is […]
Medtronic Closes $28M Purchase of QT Vascular’s Chocolate PTA Balloon Catheter
Medtronic Completes the Purchase of QT Vascular’s Chocolate PTA Balloon Catheter Highlights: – Medtronic completes the purchase of the Company’s non-drug coated Chocolate® PTA balloon catheter – The completion of this purchase validates the value of this internally developed specialty PTA to improve outcomes in patients with peripheral artery disease PLEASANTON, Calif., […]
Endologix Appoints Greg Morrow as Chief Marketing Officer and Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
IRVINE, Calif.–(BUSINESS WIRE)– Endologix Inc. (Nasdaq:ELGX), a developer and marketer of innovative treatments for aortic disorders, announced today that it has appointed Greg Morrow as the Company’s Chief Marketing Officer, effective immediately. Mr. Morrow brings to Endologix a wealth of executive marketing experience in medical devices. Most recently, he led the Coronary […]
Vascular Insights® Announces New Chief Executive Officer
QUINCY, Mass., Jan. 25, 2018 /PRNewswire/ — Vascular Insights® announced that its Board of Directors has appointed James P. Ott as President and CEO. Jim brings to the position greater than 20 years of experience as President for companies in the manufacturing and medical device industries. He has held numerous leadership positions that have focused on […]
Endologix, Inc. to Announce Fourth Quarter and Fiscal Year 2017 Financial Results on February 21, 2018
IRVINE, Calif.–(BUSINESS WIRE)– Endologix Inc. (Nasdaq: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that it will report financial results for the fourth quarter and fiscal year 2017 after the market close on Wednesday, February 21, 2018. The Company’s management will host a conference call at 4:30 […]
Advanced Bifurcation Systems Appoints Industry Veteran Thomas O’Neill to Board of Directors
LOS ANGELES, Jan. 25, 2018 (GLOBE NEWSWIRE) — Advanced Bifurcation Systems (“ABS” or the “Company”), a clinical stage medical device company developing an innovative stenting platform which overcomes the limitations of current approaches for the treatment of bifurcation lesions in coronary angioplasties, today announced the addition of Thomas O’Neill to the Board […]
Cardiovascular Systems, Inc. Appoints Rhonda Robb as New Chief Operating Officer
ST. PAUL, Minn.–(BUSINESS WIRE)– Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary artery disease, today announced that it has appointed Rhonda Robb as its new Chief Operating Officer. She will report to Scott Ward, CSI Chairman, President and Chief […]
Baylis Medical Embraces Advanced Manufacturing With Opening of State-of-the-Art Lab
TORONTO, Jan. 22, 2018 /PRNewswire/ – Baylis Medical, a global medical device company, has taken the next pivotal step in its global expansion strategy with the official opening of a new state-of-the-art laboratory in Mississauga, Ontario. The new extrusion lab will allow the company to expand its capabilities and capacity to design, […]
Neovasc Names Former BeneChill CEO as New Leader
VANCOUVER, Jan. 22, 2018 /PRNewswire/ – Neovasc (“Neovasc” or the “Company“) (Nasdaq, TSX: NVCN), a front-runner in minimally invasive transcatheter mitral valve technologies today announced that its board of directors (the “Board”) has appointed Fred A. Colen as president and chief executive officer effective immediately. This leadership transition is a key element […]